Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Maternal Hyperoxygenation for Intrapartum Fetal Heart Rate Tracing Abnormalities: a Randomized Clinical Trial

NCT03996317 is registered in ClinicalTrials.gov with Loma Linda University as lead sponsor.

NCT NCT03996317
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03996317 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Maternal Hyperoxygenation for Intrapartum Fetal Heart Rate Tracing Abnormalities: a Randomized Clinical Trial
Lead sponsor
Loma Linda University
Phase
Not applicable
Overall status
Withdrawn
Start date
June 30, 2021
Completion date
December 30, 2022
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypoxic-ischemic encephalopathy, intracranial hemorrhages, meconium aspiration syndrome, neonatal hypotension, neonatal seizure, perinatal death, respiratory distress syndrome, newborn